the dunbar difference
Quality, safety and efficacy should never be compromised in cannabinoid therapeutics
Precision Manufacturing, Advanced R&D, and Full Compliance
Commercial Manufacture of Cannabinoid APIs
EU cGMP-certified, fully inspected facility located in Ireland.
In-house manufacturing, testing, and stability programs ensuring consistent product quality.
Production of cannabinoid APIs (e.g., Dronabinol) and other specialty pharmaceutical-grade compounds.
Advanced R&D & Innovation
In-house research and development capabilities for APIs, novel cannabinoid formulations and herbal extracts.
Integrated stability studies ensuring long-term product reliability and safety
Expertise in organic cannabinoid chemistry, process optimisation, and pharmaceutical-grade synthesis.
Uncompromising Quality Control
Robust in-house Quality Control laboratory conducting rigorous analytical testing.
Comprehensive Certificates of Analysis (COAs) provided for every batch.
Consistent product Dronabinol purity of 97%-99%, with full traceability from raw plant materials to final API.
Regulatory & Global Market Compliance
Full compliance with EU and global pharmaceutical regulations.
Products exceed standards for global market access, supported by thorough regulatory documentation.
Trusted partner for stakeholders seeking highly controlled APIs in tightly regulated markets
Patient-Centred Approach
At the heart of everything we do is the patient. We believe that quality, safety, and efficacy should never be compromised in cannabinoid therapeutics. Our patient-centred philosophy is driven by the belief that cannabinoid-based medicines should meet the same rigorous standards as other pharmaceutical products – ensuring safety, consistency, and reliability for those who need it most.
Quality Without Compromise
- Every Dunbar API is manufactured under strict EU cGMP guidelines, ensuring pharmaceutical-grade purity and safety.
- Our in-house R&D and QC teams rigorously test each batch, providing healthcare professionals with products they can trust.
- We design our APIs to support precise dosing, consistent pharmacological profiles, and predictable therapeutic outcomes.
Reliable & Consistent Supply
We understand that patients rely on consistent access to their medications. Our robust supply chain, combined with in-house stability testing and proactive stock management, ensures a continuous, reliable flow of APIs to healthcare providers and pharmacies.
Therapeutic Integrity
We focus on purity and precision in our APIs, ensuring that healthcare professionals can prescribe cannabinoid therapies with confidence, free from concerns about variability, contaminants, or inconsistent dosing.
Bridging the Gap Between Science & Care
Our dedication to education and product transparency empowers healthcare providers to make informed decisions, ensuring that patients receive the safest, most effective cannabinoid-based treatments available.
Our Standards & Values
Patient-First Philosophy
Our mission is to improve patient outcomes by providing safe, effective, and consistent cannabinoid-based therapies.
Quality and Excellence in Manufacturing
We uphold the highest standards in GMP manufacturing, ensuring that every product meets stringent global regulatory requirements.
Scientific Integrity
Through continuous research and development, we advance the field of cannabinoid medicine with a commitment to data-driven innovation.
Sustainability
We are committed to environmentally conscious production practices, utilizing eco-friendly solvents and implementing sustainable manufacturing processes to minimize our ecological footprint.
Innovation
Our research-driven approach leverages cutting-edge technology and proprietary methods to develop natural cannabinoid APIs, contributing to the advancement of cannabinoid-based therapies.
Education
We believe in empowering healthcare professionals and patients through education, providing scientific resources and support to promote informed decision-making regarding cannabinoid-based therapies.
What We Do: At a Glance
APIs & cGMP Products for the Global Pharmaceutical Sector
Commercial Manufacture of APIs & cGMP Materials:
- EU cGMP Certified, Inspected Facility Specialised in API Production.
- In-House Manufacturing & Testing in Ireland
Research, Development & Stability Programs
- In-House Research and Development Centre
- Full Stability Testing to Ensure Product Integrity
- Ongoing Innovation in API Production & Formulation
Targeting Niche, Highly Controlled Markets
- Focus on hard-to-source APIs and specialty pharmaceutical compounds
- Reliable, high-purity supply chains for complex cannabinoid materials
- Meeting the needs of global pharmaceutical partners requiring precision and
quality